NSC |
Compound |
Enrichment |
Correlation |
NSC 716344 |
Null |
0.0208632511155816 |
0.46929773 |
NSC 732851 |
1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene |
0.0208632511155816 |
0.32387868 |
NSC 736164 |
pyrazoline derivative |
0.0208632511155816 |
0.45617064 |
NSC 740385 |
7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide |
0.0208632511155816 |
0.5532206 |
NSC 741942 |
Null |
0.0208632511155816 |
0.32965345 |
NSC 742327 |
(3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone |
0.0208632511155816 |
0.22922814 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0208632511155816 |
0.21150317 |
NSC 96996 |
B 169 |
0.0208632511155816 |
0.33079697 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
0.0208632511155817 |
0.3430275 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.0208632511155817 |
0.32443278 |